Erythrocyte aging characteristics in elderly individuals with beginning dementia. MEUROBIOL AGING 18(3) 291-295, 1997.-An increase in erythrocyte-bound IgG and enhanced breakdown of the erythrocyte anion exchanger band 3, characteristics of normal erythrocyte aging, are observed in old, healthy individuals when compared with young donors. These findings indicate that the rate of cellular aging increases with organismal aging. Results from previous studies on the same parameters have suggested that the erythrocyte aging process is disturbed in patients in advanced stages of Alzheimer type dementia, and in individuals with Down's syndrome who show no signs of dementia. In this study we find no changes in erythrocyte aging parameters in old individuals in beginning stages of dementia of various etiologies. We conclude that, in general, characteristics of disturbed erythrocyte aging cannot serve as presymptomatic markers of Alzheimer-type dementia. © 1997 Elsevier Science Ir,c. Aging Alzheimer Anion exchange Band 3 Dementia Erythrocyte Membrane Immunoglobulin G
SENILE dementia of the Alzheimer type (SDAT) is a syndrome with a heterologous etiology (20, 22) , However, the final neuropathological lesions, plaques, and tangles, are identical for all patients. Because plaques, tangles, and cell loss (or shrinkage) are also observed-be it to a much smaller extent-in healthy indi viduals of advanced age, the pathophysiology of SDAT has been characterized as an accelerated and/or disturbed neuronal aging process (20) .
However, too little is known about the normal neuronal aging process to falsify this hypothesis. In contrast, the final stages of the erythrocyte life are well defined (14) . Structural changes in band 3, the erythrocyte anion transporter [AE1 of the anion exchanger gene family; (4)], do not only lead to characteristic functional changes, but also to neoantigen activity and binding of autologous IgG. Cell-bound IgG, either or not in combination with comple ment activation (16) , leads to recognition and removal of old erythrocytes by the immune system (14) .
Earlier, we measured some parameters of this paradigm (IgG content, anion transport characteristics, AE1 breakdown) in eryth rocytes from patients in advanced stages of senile dementia of the Alzheimer type (SDAT), multiinfarct dementia (MID), and from age-matched control donors (3). Our results led us to the conclu sion that the erythrocyte aging process is disturbed in patients with SDAT. We reached an identical conclusion with regard to the erythrocyte aging process in donors with Down's syndrome (4) . Recent findings support the hypothesis that Alzheimer-specific changes can be found at the level of the erythrocyte membrane (23), The changes in erythrocytes from individuals with Down's syndrome who showed no signs of dementia (4) indicated that aberrant erythrocyte aging characteristics might already be detect able before the neuropsychological symptoms of dementia. Such a finding might be important for early diagnosis. Therefore, we measured erythrocyte aging characteristics (anion exchange, AE1 breakdown, IgG content) in elderly individuals with beginning dementia, and compared them with age-matched, old controls and with much younger control donors. Here we present the results of these investigations.
METHOD

Subjects
The subjects were 27 patients with senile dementia of the Alzheimer type (SDAT), 17 patients with multiinfarct dementia (MID), 9 patients with mixed dementia (SDAT/MID), and 2 control groups of subjects without dementia: one age-matched (AMC; N = 14) and one young control group (YC; N = 8). The YC were coworkers of the authors (28 ± 5 years). All other subjects were residents of local homes for the elderly, who took part in a longitudinal study on psychiatric symptoms in dementia. The present study comprises patients in the more beginning stages of dementia than the patients from a psychogeriatric institution examined previously (3) . Informed consent was obtained from all participants in the study. The demographic characteristics are presented in Table 1 .
Clinical Measurements
All subjects were scored on two cognitive screening instru ments, the Mini-Mental State Examination (7) and the Short Blessed Test (12) . Furthermore, they had undergone standardised examinations using the Clinical Assessment Battery as developed by the Consortium to Establish a Registry for Alzheimer's Disease (17) , including medical history, current medication, heteroanam nesis, neuropsychological investigation, physical and neurological examinations, a scheme for laboratory investigations, and a psy chiatric diagnosis using the Geriatric Mental State Examination (6) . Using this information, the demented subjects received a diagnosis of dementia compatible with the DSM-III-R criteria (i). According to their Hachinski score (10), they were divided into three subgroups: SDAT (score 0-4), SDAT/MID (score 5 and 6), and MID (score ^7). The age-matched control group consisted of subjects who did not fulfill the DSM-III-R criteria of dementia. The following exclusion criteria for demented and control subjects were used (17): communication problems interfering with test completion (severe hearing problems, severe aphasia), cognitive impairment caused by alcohol abuse, Parkinson's disease requiring medication, major depression, specific neurological disease with dementia (with the exception of cerebrovascular disorders and Alzheimer's disease), or an incomplete Hachinski score.
Blood Collection
Five to ten milliliters of blood, collected with EDTA as an anticoagulant, served for all assays. The assays were performed on the major erythrocyte fraction, representing "middle-aged" cells (2) . Separation of plasma, platelets, leukocytes, and young, mid dle-aged and old red blood cells was performed on the day of collection by differential centrifugation and density separation (3) .
Eiythrocyle-Bound IgG
The amount of membrane-bound immunoglobulin G (IgG) was measured on intact erythrocytes using an enzyme-linked antiglob ulin test (3) .
Anion Transport
Erythrocyte anion transport characteristics were determined by measuring initial rate of efflux of 35S-labeled sulfate (10 mCi/ mmol; Amersham, Buckinghamshire, UK) under exchange condi tions as a function of the sulfate concentration (2, 3, 13) . Km, the sulfate concentration at which the rate equals half the maximal velocity Vmax, was determined from the initial, linear part of the velocity vs. concentration graph (2, 3) .
Immunochemical Analysis
Erythrocyte membranes were prepared by hypotonic lysis in the presence of EDTA, EGTA, and diisopropylfiuorophosphate as protease inhibitors (3). Band 3 polypeptides were analyzed by sodium dodecylsulfate-polyacrylamide gelelectrophoresis and immunoblotting using standard techniques described before (3) . The reactivity of the antisera against human erythrocyte band 3 (MK1B3 against the whole protein and PMB3 against the mem brane domain) have been described before (3, 4) . Quantitative analysis of the extent of band 3 fragmentation was performed with a densitometer (GS-670) and analysis program (Molecular Ana lyst) from Bio-Rad Laboratories (Hercules, CA).
The clinical and neuropsychological data of the patients were only revealed and combined with the data from the biochemical studies after the latter had been completed.
RESULTS
Erythrocyte-Bounci Immunoglobulin G
The amount of erythrocyte-bound IgG did not differ signifi cantly between the demented and healthy, age-matched donor groups (Fig. 1) , and was in the same range as reported before for healthy, old-aged people [3.6 ± 0.9 fgm/1000 cells; (3, 4) ], This value is higher than that found for a relatively young (28 ± 5 years) control group (1.8 ± 0.8 fgm/1000 cells), confirming earlier results (4) . In contrast with earlier findings in patients in an advanced stage of dementia of the Alzheimer type (3)> we did not find a significant increase in erythrocyte-bound IgG for the SDAT group. Exclusion of the extremely high IgG values (Fig, 1) does not significantly affect these conclusions.
Anion Transport Characteristics
The mean values of Vmox and Km of sulfate exchange did not differ significantly between the various donor groups, and were not different from the previously reported values for erythrocytes of young or aged control groups [ Table 2 ; (3, 4) ]. It is noteworthy, however, that 9 of the 11 donors with Vmax values that were significantly lower than the mean (control) value (12.1 ± 2.9 (xmol/1010 cells/min), belong to the patient groups (6 SDAT; 2 SDAT/MID; 1 MID). The numbers of individuals with a Km 
Blood Chemistry
Measurement of erythrocyte, thrombocyte, and leukocyte num bers, and related parameters (hemoglobin, mean cellular volume, etc.) did not indicate any disturbances in cellular homeostasis in the patient groups as compared with the control groups. The serum concentrations of sodium, potassium, chloride, bicarbonate, and calcium, as well as those of glucose, creatinine, and urea, were within the normal range. There was a highly significant (/-= 0.52, p < 0.001, n -47) positive correlation between Vmax of sulfate exchange and hemoglobin content. We found no significant difference between the patient and control groups in the extent and type of medicines used. There was no significant correlation between any of the erythrocyte aging parameters and use of medicine, with one notable exception. The value of the Vmax of sulfate exchange was significantly correlated with the use of acetylsalicylic acid (r = 0.46, p < 0.001, n = 57).
DISCUSSION
The erythrocyte aging process seems to be accelerated in aged individuals. The increased percentage of reticulocytes, the in creased percentage of erythrocytes containing IgG, and the in crease in erythrocyte IgG content in old rats are all considered to be signs of increased removal and compensatory erythrocyte formation in aged individuals (15). Our present findings, which show an increase in erythrocyte IgG content in healthy old people and an increase in breakdown of erythrocyte band 3, confirm this conclusion for aging humans. The increased fragmentation of band 3 in the elderly supports the hypothesis that breakdown of band 3 accompanies the generation of senescent erythrocyte-specific an tigens, and, thus, in the binding of IgG (2, 14) . The Km and VmaK values of sulfate exchange, however, did not differ significantly between old and young donors. As sulfate transport is 10,000 times slower than that of the physiological-chloride/bicarbonate ex change (18) , these parameters may not be sensitive enough to detect small changes. Together, these data indicate that in old individuals the rate of the erythrocyte aging process is increased. An increased susceptibility to (calcium-activated) proteases, pos sibly due to a decrease in antioxidant activity, has been suggested for the erythrocyte aging process (13) , as well as for cellular aging in general (11, 19) . A more detailed description of the structural differences in band 3 and its fragmentation products in old vs. young erythrocytes, and in erythrocytes from young vs. those of old donors, will be instrumental in understanding the underly ing processes.
Despite the large increase in knowledge about the composition of plaques and tangles in Alzheimer's disease-affected brain areas, the processes that underly neuronal degeneration and death are far from understood (20, 22) . The neuropathological and the neuropsy chological characteristics of AD indicate a disturbance and/or acceleration of the normal neuronal aging process (5) . In addition, numerous data indicate that AD/SDAT may have specific systemic manifestations (24) . From these observations, we postulated that acceleration or disturbance of the cellular aging process in patients with AD/SDAT might be detectable at the level of the erythrocyte membrane. Our first results did indeed show an increase in erythrocyte IgG content, a change in band 3 fragmentation patterns, and a decrease in the Km of sulfate exchange in AD/ SDAT, but not in multiinfarct dementia patients, when compared with a group of age-matched control donors (3). These findings were supported by reports of protein-related differences at the surface of erythrocytes between control and SDAT patients (23) , and of irregularly shaped erythrocytes in some SDAT patients (9) . Thus, die membrane characteristics of patients in advanced stages of AD/SDAT led us to the conclusion that the erythrocyte aging process might be disturbed in these patients (3) . Measurements of the same parameters in individuals with Down's syndrome of various ages and in various stages of dementia resulted in the hypothesis that changes in the erythrocyte aging process might be detectable before the onset of dementia (4) . However, in the present study we found no disease-specific differences in any of the erythrocyte aging characteristics in aged patients with begin ning dementia, compared with age-matched controls. This differ ence between the findings in two donor groups, who were in the same age range but in different stages of dementia, could be due to various causes: 1) Although the methods used by us to establish the diagnosis of dementia and SDAT are as accurate as presently possible (see the section Clinical Measurements in the Method section), it can not be excluded that statistically significant differences may not be apparent because of this problem. 2) It is generally acknowledged that SDAT is a heterogeneous disease (20, 22) . The patients in the advanced stages of dementia described before (3) were of the same age as the patients in the beginning stages described here. Thus, these two groups may represent another illustration of the heterogeneity in age of onset and/or rate of progression of SDAT that may be reflected by the erythrocyte aging process. 3) More likely, a general disturbance of the cellular aging system in AD/SDAT underlies neuronal degeneration and cell death and may affect neuronal and erythrocyte aging equally. The constant renewal of the erythrocyte population could prevent detection of such a disturbance until at an advanced stage, i.e., after a long period of disease progress. 4) An advanced stage of dementia might run parallel with a deficiency in the maintenance of general, organismal homeostasis. A small disturbance of the already increased rate of erythrocyte aging in the elderly (15) might very well result in changes in erythrocyte homeostasis, and, thus, in the values of the erythi'ocyte aging-related parameters.
